Dual human epidermal growth factor receptor 2 blockade for the treatment of HER2-positive breast cancer

By Alvarez Ricardo  

Breast Cancer, Vol. 20, Iss. 2, 2013-04 ,pp. : 103-110

Springer Publishing Company

Access to resources Recommend Favorite

Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumab

By                      

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1109-1112

Science Publishers

Access to resources Recommend Favorite

Anthocyanins potentiate the activity of trastuzumab in human epidermal growth factor receptor 2positive breast cancer cells in vitro and in vivo

By              

Molecular Medicine Reports, Vol. 10, Iss. 4, 2014-01 ,pp. : 1921-1926

Spandidos Publications

Access to resources Recommend Favorite

Adding hormonal therapy to chemotherapy and trastuzumab improves prognosis in patients with hormone receptor-positive and human epidermal growth factor receptor 2-positive primary breast cancer

By Hayashi Naoki  

Breast Cancer Research and Treatment, Vol. 137, Iss. 2, 2013-01 ,pp. : 523-531

Springer Publishing Company

Access to resources Recommend Favorite

Gene expression profiling of histologically normal breast tissue in females with human epidermal growth factor receptor 2positive breast cancer

By  

Molecular Medicine Reports, Vol. 11, Iss. 2, 2015-01 ,pp. : 1421-1427

Spandidos Publications

Access to resources Recommend Favorite